Applied Software Announces 360 Sync v3

Applied Software, a leading systems integrator for the architecture, engineering, construction, and manufacturing industries, announced today the release of 360 Sync version 3.0.

This latest version of 360 Sync has an updated, easy-to-use interface and connects to data sources faster and easier, with more connection options. As a cross-platform Electron application, it now has improved accessibility and agility.

360 Sync synchronizes files among multiple data sources automatically or on demand, mitigating risk by updating files as often as possible. It also publishes all models in a BIM 360 project automatically or on demand. When one data source is updated, the rest sync with it.

The new version is exceptional at enabling companies to minimize the use of critical resources and reduce human error. On average, 360 Sync saves a user an hour each day simply by automating the transfer, organization and archiving of files among data sources.

360 Sync connects to: Asite, Bluebeam Studio Projects, Procore, Sharepoint, Autodesk Vault, Viewpoint 4 Projects, Windows, Box, Dropbox, Egnyte, Google Drive, Kenesto, OneDrive, Panzura, ShareFile, Teams, and the BIM 360 modules Field, Glue, Team, Docs, Build, and Design.

About Applied Software

Applied Software, a full-service premier systems integrator for the AEC, MEP, fabrication, and manufacturing industries, is on a mission to transform industries by empowering our clients and championing innovation with real-world expert consultants. With a broad range of world-class solutions, services and training, Applied has been helping clients achieve a competitive advantage since 1982. For more information visit www.asti.com.

Media contact:

Todd Weyandt

404-564-1843 

tweyandt@asti.com

Total
0
Shares
Leave a Reply
Related Posts

Emil Kakkis Joins Nonprofit Biotech Odylia Therapeutics Board of Directors

Emil Kakkis, MD, PhD, joins the Board of Directors of Odylia Therapeutics. Kakkis is the CEO, President and Founder of Ultragenyx Pharmaceutical Inc., which is committed to developing and commercializing treatments for rare and ultra-rare diseases. He brings to Odylia knowledge of the needs and opportunities in developing life-altering therapies for rare diseases. Dr. Kakkis states "Odylia is a unique organization with the potential to truly shift the way therapies are brought to market, ultimately bringing life changing treatments to people living with rare diseases. I'm looking forward to being part of their work."